Technologies
AI Star's
Unique Technical Capabilities
01
Protein-Drug
Interaction Prediction
AI
02
Data Inteligence
Pipeline
03
Multi Scale
Phase Field Simulation
04
MPPS
(Multi-Physics PINN Software)
AI-based Drug-Target Screening
Using our own collected and refined drug big data and ABCnet-based deep learning model, we analyze the relationship between the amino acid sequence of the target protein and the SMILES of the ligand.

Through this, we provide candidates with the optimal binding strength.
Efficiency Prediction Accuracy Improvement
By improving the prediction accuracy of the target protein and ligand, we provide our own deep learning-based prediction model that has improved from an average of 89% to 94%.
Nano Scale Phase Field Simulation
The software for simulating the growth of nano and micro particles analyzes the lithium-ion battery positive electrode particles thermally, predicts the crystallization pattern, particle size distribution, and porosity of the first and second particles, and systematically manages data on lithium-ion distribution, insertion efficiency, insertion active area, and mechanical stress. Through intensive analysis, we provide precise insights.
MPPs
(Multi-Physics PINN Software)
The PINN (Physics-Informed Neural Network) solution predicts material physics and complements traditional simulations with fast inference.

It integrates modules such as DFT and MD to support model development optimized for target phenomena.
Capacity Prediction Accuracy Improvement
By improving the prediction accuracy of the capacity of the material used in the secondary battery and the method of synthesis of the material, we provide our own deep learning-based prediction model that has improved from an average of 90% to 97%.
Through years of experience, we have applied for 5 patents and published 3 related papers (bioXiv, JKICS, IJCAL).
The system and method for predicting the three-dimensional structure of a target protein, including a deep learning module, and the method for predicting the interaction between a drug and a target protein
Patent - 2021 - 0013839
The method for predicting the inhibition of the causal protein of a drug-induced nervous disease using a deep learning model
Patent - 2021 - 0013835
The method for deriving drug candidates using predicted active
walls
Patent - 2020 - 0117448
The method for deriving drug candidates using predicted active
walls
Seoul International Invention Pair
The Seoul Mayor's Award for Ministry
of SMEs and Starup
2022 1655
AI Star Inc.
Ceo
Address
Biz No.
E-mail
Tel
Woojung Jang
#Floor 4-D, 39 Maehunro 8-gil Seocho-gu Seoul Korea
796-86-02777
hello@aistar.it
+82-507-1325-7197
2023 AI Star Inc. All rights reserved.